moderate ROS can sustain pro-survival pathways, whereas excessive ROS can exceed antioxidant capacity and trigger cell death ( Plant-derived polyphenols (phenolic acids, flavonoids, stilbenes, and related metabolites) ( in vitro effects often fail to translate into clinical effects because many phenolics exhibit poor solubility, instability, and rapid metabolism, which lead to low systemic bioavailability (e.g low levels in the bloodstream) and inadequate tumor exposure ( In this review, redox sensitization refers to a tumor-directed increase in oxidative pressure, or a reduction in tumor antioxidant buffering, sufficient to move malignant cells closer to an apoptotic or therapy-responsive threshold
Further studies reveal the two-way relationship between sleep and oxidative stress
Enhanced glutathione production by evolutionary engineering of Saccharomyces cerevisiae strains
Sorafenib induces ferroptosis by targeting the cystine/glutamate anti-transport system Xc- [154,155,156,157], an effect that impinges on cystine uptake, thereby preventing subsequent synthesis of glutathione (GSH), the major intracellular antioxidant, preventing GPX4 activation [158, 159], and can trigger ER stress and ferroptosis
(b) does the level of GSH influence the risk for disease of a population
IV (intravenous) therapy involves delivering fluids, medications, vitamins, and essential nutrients directly into your bloodstream, allowing for rapid and efficient absorption that bypasses the digestive system
